{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:06:00Z","timestamp":1790672760526,"version":"4.1.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T00:00:00Z","timestamp":1439856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0135314","type":"journal-article","created":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T13:57:18Z","timestamp":1439906238000},"page":"e0135314","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Detailed Functional and Proteomic Characterization of Fludarabine Resistance in Mantle Cell Lymphoma Cells"],"prefix":"10.1371","volume":"10","author":[{"given":"Lucie","family":"Lorkova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Scigelova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabiwang Ndipanquang","family":"Arrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Vit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Pospisilova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliska","family":"Doktorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Klanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmudul","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Vockova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bokang","family":"Maswabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Klener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Petrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,8,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3109\/10428194.2012.733882","article-title":"Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network","volume":"54","author":"M Dreyling","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJMoa1200920","article-title":"Treatment of older patients with mantle-cell lymphoma","volume":"367","author":"HC Kluin-Nelemans","year":"2012","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1172\/JCI61272","article-title":"Molecular pathogenesis of mantle cell lymphoma","volume":"122","author":"P Jares","year":"2012","journal-title":"J Clin Invest"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood-2004-04-1323","article-title":"The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group","volume":"104","author":"R Forstpointner","year":"2004","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1200\/JCO.2009.24.1570","article-title":"Flavopiridol, fludarabine, and rituximab in mantle cell lymphoma and indolent B-cell lymphoproliferative disorders","volume":"28","author":"TS Lin","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00003088-200241020-00002","article-title":"Cellular and clinical pharmacology of fludarabine","volume":"41","author":"V Gandhi","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mrfmmm.2008.08.013","article-title":"Non-homologous end joining is the responsible pathway for the repair of fludarabine-induced DNA double strand breaks in mammalian cells","volume":"646","author":"M de Campos-Nebel","year":"2008","journal-title":"Mutat Res"},{"key":"ref8","first-page":"5956","article-title":"Molecular and biochemical mechanisms of fludarabine and cladribine resistance in a human promyelocytic cell line","volume":"59","author":"E M\u00e5nsson","year":"1999","journal-title":"Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0006-2952(02)01484-3","article-title":"Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance","volume":"65","author":"E M\u00e5nsson","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2004-03-1046","article-title":"Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and-insensitive populations","volume":"105","author":"JR Mackey","year":"2005","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1038\/sj.leu.2402579","article-title":"Mechanisms of resistance to nucleoside analogue chemotherapy in mantle cell lymphoma: a molecular case study","volume":"16","author":"T Reiman","year":"2002","journal-title":"Leukemia"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1476-4598-9-115","article-title":"Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia","volume":"9","author":"E Moussay","year":"2010","journal-title":"Mol Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1182\/blood-2011-03-340364","article-title":"An antiapoptotic BCL-2 family expression index predicts the response of chronic lymphocytic leukemia to ABT-737","volume":"118","author":"S Al-Harbi","year":"2011","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e628","DOI":"10.1038\/cddis.2013.155","article-title":"BECN1 and BIM interactions with MCL-1 determine fludarabine resistance in leukemic B cells","volume":"4","author":"A Sharma","year":"2013","journal-title":"Cell Death Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.bbrc.2003.10.054","article-title":"Involvement of p53 in alpha4beta1 integrin-mediated resistance of B-CLL cells to fludarabine","volume":"311","author":"MT de la Fuente","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1182\/blood-2009-05-224071","article-title":"Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial","volume":"114","author":"T Zenz","year":"2009","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1182\/blood-2013-10-534271","article-title":"Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness","volume":"123","author":"M Messina","year":"2014","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1182\/blood-2011-12-395673","article-title":"Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia","volume":"119","author":"D Rossi","year":"2012","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1158\/1541-7786.MCR-14-0124","article-title":"Targeting mTORC1-mediated metabolic addiction overcomes fludarabine resistance in malignant B cells","volume":"12","author":"A Sharma","year":"2014","journal-title":"Mol Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.1200\/JCO.2007.11.2649","article-title":"Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion","volume":"25","author":"B Austen","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0145-2126(02)00013-9","article-title":"Establishment and characterization of a new mantle cell lymphoma cell line, Mino","volume":"26","author":"R Lai","year":"2002","journal-title":"Leuk Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth.1322","article-title":"Universal sample preparation method for proteome analysis","volume":"6","author":"JR Wi\u015bniewski","year":"2009","journal-title":"Nat Methods"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1021\/pr800982s","article-title":"Accurate and sensitive peptide identification with Mascot Percolator","volume":"8","author":"M Brosch","year":"2009","journal-title":"J Proteome Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1074\/mcp.M200025-MCP200","article-title":"Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics","volume":"1","author":"SE Ong","year":"2002","journal-title":"Mol Cell Proteomics"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0163-7258(95)00015-9","article-title":"Mammalian deoxyribonucleoside kinases","volume":"67","author":"ES Arn\u00e9r","year":"1995","journal-title":"Pharmacol Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s004320050185","article-title":"Mechanisms responsible for resistance of sublines derived from leukemia cell lines to an antitumor agent 9-beta-D-arabinofuranosyl-2-fluoroadenine","volume":"124","author":"L Bai","year":"1998","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref27","first-page":"2438","article-title":"Biochemical pharmacology and resistance to 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, a novel analogue of cladribine in human leukemic cells","volume":"5","author":"K Lotfi","year":"1999","journal-title":"Clin Cancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e23372","DOI":"10.1371\/journal.pone.0023372","article-title":"Mechanisms of resistance to decitabine in the myelodysplastic syndrome","volume":"6","author":"T Qin","year":"2011","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1476-4598-13-159","article-title":"Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents","volume":"13","author":"M Klanova","year":"2014","journal-title":"Mol Cancer"},{"key":"ref30","first-page":"2475","article-title":"Enzymic capacities of purine de novo and salvage pathways for nucleotide synthesis in normal and neoplastic tissues","volume":"44","author":"Y Natsumeda","year":"1984","journal-title":"Cancer Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1084\/jem.20121061","article-title":"Nucleoside salvage pathway kinases regulate hematopoiesis by linking nucleotide metabolism with replication stress","volume":"209","author":"WR Austin","year":"2012","journal-title":"J Exp Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.molcel.2006.01.036","article-title":"Condensin I interacts with the PARP-1-XRCC1 complex and functions in DNA single-strand break repair","volume":"21","author":"JT Heale","year":"2006","journal-title":"Mol Cell"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1091\/mbc.E14-05-0957","article-title":"Condensin suppresses recombination and regulates double-strand break processing at the repetitive ribosomal DNA array to ensure proper chromosome segregation during meiosis in budding yeast","volume":"25","author":"P Li","year":"2014","journal-title":"Mol Biol Cell"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00412-011-0349-2","article-title":"Rescue of replication failure by Fanconi anaemia proteins","volume":"121","author":"A Constantinou","year":"2012","journal-title":"Chromosoma"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"11517","DOI":"10.1093\/nar\/gku840","article-title":"A gemcitabine sensitivity screen identifies a role for NEK9 in the replication stress response","volume":"42","author":"SC Smith","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0092-8674(93)90509-O","article-title":"Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death","volume":"74","author":"ZN Oltvai","year":"1993","journal-title":"Cell"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1172\/JCI118684","article-title":"Balancing cell life and death: bax, apoptosis, and breast cancer","volume":"97","author":"JC Reed","year":"1996","journal-title":"J Clin Invest"},{"key":"ref38","first-page":"9","article-title":"Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies","volume":"34","author":"JC Reed","year":"1997","journal-title":"Semin Hematol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"AJ Souers","year":"2013","journal-title":"Nat Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/MOH.0000000000000057","article-title":"Do mantle cell lymphomas have an 'Achilles heel'?","volume":"21","author":"N Saba","year":"2014","journal-title":"Curr Opin Hematol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1306220","article-title":"Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma","volume":"369","author":"ML Wang","year":"2013","journal-title":"N Engl J Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-065X.2000.imr017504.x","article-title":"The role of Bruton's tyrosine kinase in B-cell development and function: a genetic perspective","volume":"175","author":"AB Satterthwaite","year":"2000","journal-title":"Immunol Rev"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.leukres.2013.07.028","article-title":"Bruton tyrosine kinase is commonly overexpressed in mantle cell lymphoma and its attenuation by Ibrutinib induces apoptosis","volume":"37","author":"M Cinar","year":"2013","journal-title":"Leuk Res"},{"key":"ref44","article-title":"B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells","author":"V Seda","year":"2015","journal-title":"Eur J Haematol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/1074-7613(95)90075-6","article-title":"Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection","volume":"2","author":"JG Cyster","year":"1995","journal-title":"Immunity"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1476-4598-7-14","article-title":"Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cells","volume":"7","author":"N Vi\u00e9","year":"2008","journal-title":"Mol Cancer"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.canlet.2010.09.003","article-title":"Overexpression of biliverdin reductase enhances resistance to chemotherapeutics","volume":"300","author":"U Florczyk","year":"2011","journal-title":"Cancer Lett"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.bbrc.2013.09.120","article-title":"Biliverdin reductase plays a crucial role in hypoxia-induced chemoresistance in human glioblastoma","volume":"440","author":"SS Kim","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"ref49","first-page":"4313","article-title":"Glutathione-associated enzymes in anticancer drug resistance","volume":"54","author":"KD Tew","year":"1994","journal-title":"Cancer Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/emmm.201100626","article-title":"Aminoacyl-tRNA synthetases in medicine and disease","volume":"5","author":"P Yao","year":"2013","journal-title":"EMBO Mol Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0135314","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T21:02:47Z","timestamp":1540242167000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0135314"}},"subtitle":[],"editor":[{"given":"Yiqun G.","family":"Shellman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,18]]},"references-count":50,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0135314","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,18]]}}}